Rotavirus genotypes and clinical outcome of natural infection based on vaccination status in the post-vaccine era

• Main Authors: Kei Kozawa (Author), Yuki Higashimoto (Author), Yoshiki Kawamura (Author), Hiroki Miura (Author), Takumi Negishi (Author), Fumihiko Hattori (Author), Masaru Ihira (Author), Satoshi Komoto (Author), Koki Taniguchi (Author), Tetsushi Yoshikawa (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Rotavirus (RV) is a leading cause of gastroenteritis in children. In Japan, Rotarix (RV1; GlaxoSmithKline), which is a monovalent vaccine derived from human RV (G1P[8]), has been introduced since November 2011, and RotaTeq (RV5; MSD) which is an pentavalent, human-bovine mono-reassortant vaccine (G1...